Report Detail
COVID-19 Impact on Global Biosimilar Insulin, Market Insights and Forecast to 2026
- RnM4073138 |
- 23 June, 2020 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
Biosimilar Insulin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilar Insulin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Biosimilar Insulin market is segmented into
Rapid Acting Insulins
Short Acting Insulins
Intermediate Insulins
Long Lasting Insulins
Segment by Application, the Biosimilar Insulin market is segmented into
Hospital
Clinic
Medical Center
Regional and Country-level Analysis
The Biosimilar Insulin market is analysed and market size information is provided by regions (countries).
The key regions covered in the Biosimilar Insulin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Biosimilar Insulin Market Share Analysis
Biosimilar Insulin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biosimilar Insulin business, the date to enter into the Biosimilar Insulin market, Biosimilar Insulin product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Biogenomics
Eli Lilly
Gan&Lee Pharmaceuticals
Geropharm
Julphar Gulf Pharmaceutical Industries
Paras Biopharmaceuticals
Samsung Bioepis
Sedico
Wockhardt
Teva Pharmaceuticals
1 Study Coverage
- 1.1 Biosimilar Insulin Product Introduction
- 1.2 Market Segments
- 1.3 Key Biosimilar Insulin Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Biosimilar Insulin Market Size Growth Rate by Type
- 1.4.2 Rapid Acting Insulins
- 1.4.3 Short Acting Insulins
- 1.4.4 Intermediate Insulins
- 1.4.5 Long Lasting Insulins
- 1.5 Market by Application
- 1.5.1 Global Biosimilar Insulin Market Size Growth Rate by Application
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Medical Center
- 1.6 Coronavirus Disease 2019 (Covid-19): Biosimilar Insulin Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Biosimilar Insulin Industry
- 1.6.1.1 Biosimilar Insulin Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Biosimilar Insulin Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Biosimilar Insulin Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Biosimilar Insulin Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Biosimilar Insulin Market Size Estimates and Forecasts
- 2.1.1 Global Biosimilar Insulin Revenue 2015-2026
- 2.1.2 Global Biosimilar Insulin Sales 2015-2026
- 2.2 Biosimilar Insulin Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Biosimilar Insulin Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Biosimilar Insulin Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Biosimilar Insulin Competitor Landscape by Players
- 3.1 Biosimilar Insulin Sales by Manufacturers
- 3.1.1 Biosimilar Insulin Sales by Manufacturers (2015-2020)
- 3.1.2 Biosimilar Insulin Sales Market Share by Manufacturers (2015-2020)
- 3.2 Biosimilar Insulin Revenue by Manufacturers
- 3.2.1 Biosimilar Insulin Revenue by Manufacturers (2015-2020)
- 3.2.2 Biosimilar Insulin Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Biosimilar Insulin Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Biosimilar Insulin Revenue in 2019
- 3.2.5 Global Biosimilar Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Biosimilar Insulin Price by Manufacturers
- 3.4 Biosimilar Insulin Manufacturing Base Distribution, Product Types
- 3.4.1 Biosimilar Insulin Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Biosimilar Insulin Product Type
- 3.4.3 Date of International Manufacturers Enter into Biosimilar Insulin Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Biosimilar Insulin Market Size by Type (2015-2020)
- 4.1.1 Global Biosimilar Insulin Sales by Type (2015-2020)
- 4.1.2 Global Biosimilar Insulin Revenue by Type (2015-2020)
- 4.1.3 Biosimilar Insulin Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Biosimilar Insulin Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Biosimilar Insulin Sales Forecast by Type (2021-2026)
- 4.2.2 Global Biosimilar Insulin Revenue Forecast by Type (2021-2026)
- 4.2.3 Biosimilar Insulin Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Biosimilar Insulin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Biosimilar Insulin Market Size by Application (2015-2020)
- 5.1.1 Global Biosimilar Insulin Sales by Application (2015-2020)
- 5.1.2 Global Biosimilar Insulin Revenue by Application (2015-2020)
- 5.1.3 Biosimilar Insulin Price by Application (2015-2020)
- 5.2 Biosimilar Insulin Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Biosimilar Insulin Sales Forecast by Application (2021-2026)
- 5.2.2 Global Biosimilar Insulin Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Biosimilar Insulin Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Biosimilar Insulin by Country
- 6.1.1 North America Biosimilar Insulin Sales by Country
- 6.1.2 North America Biosimilar Insulin Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Biosimilar Insulin Market Facts & Figures by Type
- 6.3 North America Biosimilar Insulin Market Facts & Figures by Application
7 Europe
- 7.1 Europe Biosimilar Insulin by Country
- 7.1.1 Europe Biosimilar Insulin Sales by Country
- 7.1.2 Europe Biosimilar Insulin Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Biosimilar Insulin Market Facts & Figures by Type
- 7.3 Europe Biosimilar Insulin Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Biosimilar Insulin by Region
- 8.1.1 Asia Pacific Biosimilar Insulin Sales by Region
- 8.1.2 Asia Pacific Biosimilar Insulin Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Biosimilar Insulin Market Facts & Figures by Type
- 8.3 Asia Pacific Biosimilar Insulin Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Biosimilar Insulin by Country
- 9.1.1 Latin America Biosimilar Insulin Sales by Country
- 9.1.2 Latin America Biosimilar Insulin Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Biosimilar Insulin Market Facts & Figures by Type
- 9.3 Central & South America Biosimilar Insulin Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Biosimilar Insulin by Country
- 10.1.1 Middle East and Africa Biosimilar Insulin Sales by Country
- 10.1.2 Middle East and Africa Biosimilar Insulin Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Biosimilar Insulin Market Facts & Figures by Type
- 10.3 Middle East and Africa Biosimilar Insulin Market Facts & Figures by Application
11 Company Profiles
- 11.1 Pfizer
- 11.1.1 Pfizer Corporation Information
- 11.1.2 Pfizer Description, Business Overview and Total Revenue
- 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Pfizer Biosimilar Insulin Products Offered
- 11.1.5 Pfizer Recent Development
- 11.2 Biogenomics
- 11.2.1 Biogenomics Corporation Information
- 11.2.2 Biogenomics Description, Business Overview and Total Revenue
- 11.2.3 Biogenomics Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Biogenomics Biosimilar Insulin Products Offered
- 11.2.5 Biogenomics Recent Development
- 11.3 Eli Lilly
- 11.3.1 Eli Lilly Corporation Information
- 11.3.2 Eli Lilly Description, Business Overview and Total Revenue
- 11.3.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Eli Lilly Biosimilar Insulin Products Offered
- 11.3.5 Eli Lilly Recent Development
- 11.4 Gan&Lee Pharmaceuticals
- 11.4.1 Gan&Lee Pharmaceuticals Corporation Information
- 11.4.2 Gan&Lee Pharmaceuticals Description, Business Overview and Total Revenue
- 11.4.3 Gan&Lee Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Gan&Lee Pharmaceuticals Biosimilar Insulin Products Offered
- 11.4.5 Gan&Lee Pharmaceuticals Recent Development
- 11.5 Geropharm
- 11.5.1 Geropharm Corporation Information
- 11.5.2 Geropharm Description, Business Overview and Total Revenue
- 11.5.3 Geropharm Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Geropharm Biosimilar Insulin Products Offered
- 11.5.5 Geropharm Recent Development
- 11.6 Julphar Gulf Pharmaceutical Industries
- 11.6.1 Julphar Gulf Pharmaceutical Industries Corporation Information
- 11.6.2 Julphar Gulf Pharmaceutical Industries Description, Business Overview and Total Revenue
- 11.6.3 Julphar Gulf Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Products Offered
- 11.6.5 Julphar Gulf Pharmaceutical Industries Recent Development
- 11.7 Paras Biopharmaceuticals
- 11.7.1 Paras Biopharmaceuticals Corporation Information
- 11.7.2 Paras Biopharmaceuticals Description, Business Overview and Total Revenue
- 11.7.3 Paras Biopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Paras Biopharmaceuticals Biosimilar Insulin Products Offered
- 11.7.5 Paras Biopharmaceuticals Recent Development
- 11.8 Samsung Bioepis
- 11.8.1 Samsung Bioepis Corporation Information
- 11.8.2 Samsung Bioepis Description, Business Overview and Total Revenue
- 11.8.3 Samsung Bioepis Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Samsung Bioepis Biosimilar Insulin Products Offered
- 11.8.5 Samsung Bioepis Recent Development
- 11.9 Sedico
- 11.9.1 Sedico Corporation Information
- 11.9.2 Sedico Description, Business Overview and Total Revenue
- 11.9.3 Sedico Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Sedico Biosimilar Insulin Products Offered
- 11.9.5 Sedico Recent Development
- 11.10 Wockhardt
- 11.10.1 Wockhardt Corporation Information
- 11.10.2 Wockhardt Description, Business Overview and Total Revenue
- 11.10.3 Wockhardt Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Wockhardt Biosimilar Insulin Products Offered
- 11.10.5 Wockhardt Recent Development
- 11.1 Pfizer
- 11.1.1 Pfizer Corporation Information
- 11.1.2 Pfizer Description, Business Overview and Total Revenue
- 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Pfizer Biosimilar Insulin Products Offered
- 11.1.5 Pfizer Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Biosimilar Insulin Market Estimates and Projections by Region
- 12.1.1 Global Biosimilar Insulin Sales Forecast by Regions 2021-2026
- 12.1.2 Global Biosimilar Insulin Revenue Forecast by Regions 2021-2026
- 12.2 North America Biosimilar Insulin Market Size Forecast (2021-2026)
- 12.2.1 North America: Biosimilar Insulin Sales Forecast (2021-2026)
- 12.2.2 North America: Biosimilar Insulin Revenue Forecast (2021-2026)
- 12.2.3 North America: Biosimilar Insulin Market Size Forecast by Country (2021-2026)
- 12.3 Europe Biosimilar Insulin Market Size Forecast (2021-2026)
- 12.3.1 Europe: Biosimilar Insulin Sales Forecast (2021-2026)
- 12.3.2 Europe: Biosimilar Insulin Revenue Forecast (2021-2026)
- 12.3.3 Europe: Biosimilar Insulin Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Biosimilar Insulin Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Biosimilar Insulin Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Biosimilar Insulin Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Biosimilar Insulin Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Biosimilar Insulin Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Biosimilar Insulin Sales Forecast (2021-2026)
- 12.5.2 Latin America: Biosimilar Insulin Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Biosimilar Insulin Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Biosimilar Insulin Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Biosimilar Insulin Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Biosimilar Insulin Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Biosimilar Insulin Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Biosimilar Insulin Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Biosimilar Insulin Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Biosimilar Insulin. Industry analysis & Market Report on COVID-19 Impact on Global Biosimilar Insulin is a syndicated market report, published as COVID-19 Impact on Global Biosimilar Insulin, Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Biosimilar Insulin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
